COVID-19 Clinical Trial
Official title:
Worldwide Trends on COVID-19 Research After the Declaration of COVID-19 Pandemic: An Observational Study
On 11th of March 2020, WHO characterized COVID-19 infection as a Pandemic. After the COVID-19 infection is declared as a Pandemic there was an outburst regarding COVID-19 Research. The Research interest led to registration of Interventional and Observational studies world wide. There are constant efforts by Health care workers to seek information regarding the Interventional and Observational studies which can help in decision making regarding effective handling of COVID-19 infected patients. It is also important to track on the happenings in various frontiers of COVID-19 Research in view of historical interest and clinical relevance. This Observational Cross sectional study aims to explore the completed Researches in WHO-compliant registries to understand the trends of COVID-19 Research. This study aims to get a birds eye view of ongoing COVID-19 Research scenario worldwide. This study results can directly benefit the worldwide Academicians and Health Care Professionals to understand the ongoing COVID-19 Research trends.
On 11th of March 2020, WHO characterized COVID-19 infection as a Pandemic. After the COVID-19
infection is declared as a Pandemic there was an outburst regarding COVID-19 Research. The
Research interest led to registration of Interventional and Observational studies world wide.
AIMs & Objectives of the Study This Observational Cross sectional study aims to explore the
completed Researches in WHO-compliant registries to understand the trends of COVID-19
Research.
This study results can directly benefit the worldwide Academicians and Health Care
Professionals to understand the ongoing COVID-19 Research trends.
Primary Outcomes of the Study To understand the geographical distribution of the
interventional studies after 11th of March 2020.
To understand the geographical distribution of the Observational studies after 11th of March
2020.
To understand the monthly Research study completion rate as per geographic distribution of
the Research.
Secondary Outcomes of the Study To understand the statistical correlation of the
interventional studies Research with developed, developing and under developed countries.
To understand the statistical correlation of the observational studies Research with
developed, developing and under developed countries.
To understand the statistical correlation of the Drug based interventional studies Research
with developed, developing and under developed countries.
To understand the statistical correlation of the Diagnostic test based interventional studies
Research with developed, developing and under developed countries.
To understand the statistical correlation of the Device based interventional studies Research
with developed, developing and under developed countries.
Methodology WHO-compliant registries will be explored for completed COVID-19 Research
articles.
Inclusion Criteria Interventional studies in the WHO-compliant registries database which are
registered and completed after 11th of March 2020 until 15th of August 2020.
Observational studies in the WHO-compliant registries database which are registered and
completed after 11th of March 2020 until 15th of August 2020.
Exclusion Criteria Interventional studies in the WHO-compliant registries database which are
registered and completed before 11th March 2020.
Observational studies in the WHO-compliant registries database which are registered and
completed before 11th March 2020.
The articles selected from the WHO-compliant registries database will be categorized as per
following relevance:
Interventional Studies: Theses studies will be further categorized based on type of
Intervention. Inteventional studies can be Drug, Diagnostic tests, Rehabilitation, Procedure,
Device, Behavioral, Dietary supplement, Biological, Physiotherapy & Others types of
Interventional study.
Observational Studies: Prospective and Retrospective Observational studies.
The Studies will be mapped according to the Country where the Research is completed and the
type of Research.
Type of Variables studied in this Study 6 Continuous variables are studied in this Study
Number of Interventional Studies (Continuous variable) Number of Observational Studies
(Continuous variable) Number of Drug based Interventional Study (Continuous variable) Number
of Diagnostic test based interventional study (Continuous variable) Number of Device based
interventional study (Continuous variable) Monthly Research study completion rate (Continuous
variable)
8 Categorical variables will be studies in this study Interventional Study (Categorical
variable) Observational Study (Categorical variable) Developed country (Categorical variable)
Developing country (Categorical variable) Under developed country (Categorical variable) Drug
based Interventional Study (Categorical variable) Diagnostic test based interventional study
(Categorical variable) Device based interventional study (Categorical variable)
Statistical Analysis Data analysis will be carried out using SPSS 22.00 (Stata Corp, College
Station, TX, USA). The Data obtained will be analysed for the normal distribution. If the
data follows normal distribution curve, Pearson Correlation statistical test will be used to
assess the Correlation of categorical and continuous variables. If the data does not follow
normal distribution curve, Spearman Correlation or Chi square statistical test will be used
to assess the Correlation of Categorical and continuous variables. The p-value (significance
level) of the correlation will be determined. If the p-value is <5%, then the correlation
between variables analysed will be considered as significant.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Withdrawn |
NCT06065033 -
Exercise Interventions in Post-acute Sequelae of Covid-19
|
N/A | |
| Completed |
NCT06267534 -
Mindfulness-based Mobile Applications Program
|
N/A | |
| Completed |
NCT05047601 -
A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection
|
Phase 2/Phase 3 | |
| Recruiting |
NCT05323760 -
Functional Capacity in Patients Post Mild COVID-19
|
N/A | |
| Recruiting |
NCT04481633 -
Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection
|
N/A | |
| Completed |
NCT04612972 -
Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) to Prevent COVID-19 in Healthy Adult Population In Peru Healthy Adult Population In Peru
|
Phase 3 | |
| Completed |
NCT04537949 -
A Trial Investigating the Safety and Effects of One BNT162 Vaccine Against COVID-19 in Healthy Adults
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05494424 -
Cognitive Rehabilitation in Post-COVID-19 Condition
|
N/A | |
| Active, not recruiting |
NCT06039449 -
A Study to Investigate the Prevention of COVID-19 withVYD222 in Adults With Immune Compromise and in Participants Aged 12 Years or Older Who Are at Risk of Exposure to SARS-CoV-2
|
Phase 3 | |
| Enrolling by invitation |
NCT05589376 -
You and Me Healthy
|
||
| Completed |
NCT05158816 -
Extracorporal Membrane Oxygenation for Critically Ill Patients With COVID-19
|
||
| Recruiting |
NCT04341506 -
Non-contact ECG Sensor System for COVID19
|
||
| Completed |
NCT04384445 -
Zofin (Organicell Flow) for Patients With COVID-19
|
Phase 1/Phase 2 | |
| Completed |
NCT04512079 -
FREEDOM COVID-19 Anticoagulation Strategy
|
Phase 4 | |
| Completed |
NCT05975060 -
A Study to Evaluate the Safety and Immunogenicity of an (Omicron Subvariant) COVID-19 Vaccine Booster Dose in Previously Vaccinated Participants and Unvaccinated Participants.
|
Phase 2/Phase 3 | |
| Active, not recruiting |
NCT05542862 -
Booster Study of SpikoGen COVID-19 Vaccine
|
Phase 3 | |
| Withdrawn |
NCT05621967 -
Phonation Therapy to Improve Symptoms and Lung Physiology in Patients Referred for Pulmonary Rehabilitation
|
N/A | |
| Terminated |
NCT05487040 -
A Study to Measure the Amount of Study Medicine in Blood in Adult Participants With COVID-19 and Severe Kidney Disease
|
Phase 1 | |
| Terminated |
NCT04498273 -
COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80
|
Phase 3 | |
| Active, not recruiting |
NCT06033560 -
The Effect of Non-invasive Respiratory Support on Outcome and Its Risks in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2)-Related Hypoxemic Respiratory Failure
|